These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 16092617)

  • 1. Time to retool as CABG volume shrinks.
    OR Manager; 2005 Jul; 21(7):17-8. PubMed ID: 16092617
    [No Abstract]   [Full Text] [Related]  

  • 2. Could your financial health be heading for heart break?
    Finarelli HJ
    Healthc Financ Manage; 2003 Aug; 57(8):68-72. PubMed ID: 12938623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How hospitals respond to cardiac care turmoil.
    Johnson DE
    Health Care Strateg Manage; 2004 Apr; 22(4):2-3. PubMed ID: 15141643
    [No Abstract]   [Full Text] [Related]  

  • 4. Trends in percutaneous versus surgical revascularization of unprotected left main coronary stenosis in the drug-eluting stent era: a report from the American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR).
    Huang HW; Brent BN; Shaw RE
    Catheter Cardiovasc Interv; 2006 Dec; 68(6):867-72. PubMed ID: 17080468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Slowing of cardiac procedures termed 'ominous'.
    OR Manager; 1994 Dec; 10(12):1, 13. PubMed ID: 10139068
    [No Abstract]   [Full Text] [Related]  

  • 6. Stents versus bypass grafting for left main coronary artery disease.
    Tayek JA
    N Engl J Med; 2008 Jul; 359(4):424; author reply 425. PubMed ID: 18655244
    [No Abstract]   [Full Text] [Related]  

  • 7. Coronary artery bypass surgery versus percutaneous coronary intervention with drug-eluting stent implantation in patients with multivessel coronary disease.
    Yang ZK; Shen WF; Zhang RY; Kong Y; Zhang JS; Hu J; Zhang Q; Ding FH
    J Interv Cardiol; 2007 Feb; 20(1):10-6. PubMed ID: 17300391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simplicity makes St Luke's the best performer in CABG.
    Mathias JM
    OR Manager; 1997 May; 13(5):1, 15. PubMed ID: 10167348
    [No Abstract]   [Full Text] [Related]  

  • 9. More stents, fewer LIMAs?
    Rizik DG
    J Invasive Cardiol; 2005 Nov; 17(11):587-8. PubMed ID: 16264202
    [No Abstract]   [Full Text] [Related]  

  • 10. Changes in patterns of coronary revascularization strategies for patients with acute coronary syndromes (from the CRUSADE Quality Improvement Initiative).
    Gogo PB; Dauerman HL; Mulgund J; Ohman EM; Patel MR; Cohen DJ; Saucedo JF; Harrington RA; Gibler WB; Smith SC; Peterson ED; Roe MT;
    Am J Cardiol; 2007 May; 99(9):1222-6. PubMed ID: 17478146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current percutaneous coronary intervention and coronary artery bypass grafting practices for three-vessel and left main coronary artery disease. Insights from the SYNTAX run-in phase.
    Kappetein AP; Dawkins KD; Mohr FW; Morice MC; Mack MJ; Russell ME; Pomar J; Serruys PW
    Eur J Cardiothorac Surg; 2006 Apr; 29(4):486-91. PubMed ID: 16497510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initial impact of drug-eluting stents on coronary artery bypass graft surgery.
    Liddicoat JR; De La Torre R; Ho KK; Nathan S; Levitsky S; Krempin J; Sellke F
    Ann Thorac Surg; 2006 Apr; 81(4):1239-42; discussion 1242. PubMed ID: 16564250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of the real-world use of drug-eluting stents at 9-month follow-up: results from the Sicilian DES Registry.
    Tamburino C; Barbagallo R; Capodanno D; di Matteo S; Colombo GL; Recchia M; Ciriminna S;
    J Cardiovasc Med (Hagerstown); 2009 Apr; 10(4):322-9. PubMed ID: 19430343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proceedings of the Victorian Heart Centre.
    Buxton BF
    Heart Lung Circ; 2005; 14 Suppl 2():S1. PubMed ID: 16352278
    [No Abstract]   [Full Text] [Related]  

  • 15. Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease.
    Hueb W; Lopes NH; Gersh BJ; Soares P; Machado LA; Jatene FB; Oliveira SA; Ramires JA
    Circulation; 2007 Mar; 115(9):1082-9. PubMed ID: 17339566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Taking it to heart. Availability of emergency angioplasty could be key to best outcomes for heart attack patients--but offering the service might not be so healthy for a hospital's finances.
    Becker C
    Mod Healthc; 2004 Jan; 34(2):28-9. PubMed ID: 14959636
    [No Abstract]   [Full Text] [Related]  

  • 17. Improving cardiac care: beyond institutional walls.
    Brewster C; Mattis A; Monik N; Mueller R
    Qual Lett Healthc Lead; 1993 Nov; 5(9):24-30. PubMed ID: 10130325
    [No Abstract]   [Full Text] [Related]  

  • 18. Outcomes of coronary artery bypass grafting versus percutaneous coronary intervention with drug-eluting stents for patients with multivessel coronary artery disease.
    Javaid A; Steinberg DH; Buch AN; Corso PJ; Boyce SW; Pinto Slottow TL; Roy PK; Hill P; Okabe T; Torguson R; Smith KA; Xue Z; Gevorkian N; Suddath WO; Kent KM; Satler LF; Pichard AD; Waksman R
    Circulation; 2007 Sep; 116(11 Suppl):I200-6. PubMed ID: 17846304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronary artery bypass graft vs. percutaneous coronary angioplasty: CABG on the rebound?
    Taggart DP
    Curr Opin Cardiol; 2007 Nov; 22(6):517-23. PubMed ID: 17921738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Volume-outcome relationships for percutaneous coronary interventions in the stent era.
    Hannan EL; Wu C; Walford G; King SB; Holmes DR; Ambrose JA; Sharma S; Katz S; Clark LT; Jones RH
    Circulation; 2005 Aug; 112(8):1171-9. PubMed ID: 16103238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.